Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yang, Wei  [Clear All Filters]
2024
Sun T, Liu B, Cao Y, Li Y, Cai L, Yang W. AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy. Cancer Lett. 2024;583:216605.
Zhang X, Xu N, Yang Y, Lin H, Liu B, Du X, Liu X, Liang R, Chen C, Huang J, et al. Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study. Clin Lymphoma Myeloma Leuk. 2024.
Lin X, Guan T, Xu Y, Li Y, Lin Y, Chen S, Chen Y, Wei X, Li D, Cui Y, et al. Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma. Front Immunol. 2024;15:1337489.
Hamazaki N, Yang W, Kubo C, Qiu C, Martin BK, Garge RK, Regalado SG, Nichols E, Lee C, Daza RM, et al. Induction and staging of human gastruloids with neural tube, segmented somites & advanced cell types. bioRxiv. 2024.
Yang W, Qiu C, Lv H, Zhang Z, Yao T, Huang L, Wu G, Zhang X, Chen J, He Y. Sirt3 Protects Retinal Pigment Epithelial Cells From High Glucose-Induced Injury by Promoting Mitophagy Through the AMPK/mTOR/ULK1 Pathway. Transl Vis Sci Technol. 2024;13(3):19.
Sun T, Liu B, Cai L, Zhou Y, Yang W, Li Y. Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy. J Neurooncol. 2024.
2023
Li Y, Yang W, Wang HC, Patel RM, Casey EB, Denby ED, Magee JA. Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis. Blood Adv. 2023.
Ma N, Zhao S, Yang W, Wang Y. B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells. Arab J Gastroenterol. 2023.
Chen W, Wang Y, Zheng J, Chen Y, Zhang C, Yang W, Wu L, Yang Z, Wang Y, Shi C. Characterization of cellular senescence in radiation ulcers and therapeutic effects of mesenchymal stem cell-derived conditioned medium. Burns Trauma. 2023;11:tkad001.
Yuan X, Yang W, Fu Y, Tao Z, Xiao L, Zheng Q, Wu D, Zhang M, Li L, Lu Z, et al. Four-arm Polymer-Guided Formation of Curcumin-Loaded Flower-Like Porous Microspheres As Injectable Cell Carriers For Diabetic Wound Healing. Adv Healthc Mater. 2023:e2301486.
Zhang Z-M, Yu P, Zhou K, Yu F-Y, Bao R-Y, Yang M-Bo, Qian Z-Y, Yang W. Hierarchically Porous Implants Orchestrating a Physiological Viscoelastic and Piezoelectric Microenvironment for Bone Regeneration. Adv Healthc Mater. 2023:e2300713.
Yang S, Zhang X, Gale RPeter, Du X, Chen C-Y, Weng J-Y, Huang J, Li F, Zeng Y, Xiao Z, et al. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol. 2023.
Sun L, Yang N, Chen B, Bei Y, Kang Z, Zhang C, Zhang N, Xu P, Yang W, Wei J, et al. A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharm Sin B. 2023;13(7):3027-3042.
Bai X, Chen T, Li Y, Ge X, Qiu C, Gou H, Wei S, Liu T, Yang W, Yang L, et al. PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis. Stem Cell Res Ther. 2023;14(1):370.
Ruan B, Zhu Z, Yan Z, Yang W, Zhai D, Wang L, Ye Z, Lu H, Xiang A, Liang J, et al. Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway. Stem Cell Res Ther. 2023;14(1):275.
Yang W, Xu M, Xu S, Guan Q, Geng S, Wang J, Wei W, Xu H, Liu Y, Meng Y, et al. Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. Breast Cancer Res. 2023;25(1):100.
Zhang X, Gale RPeter, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, et al. Validation of the imatinib-therapy failure model. Leukemia. 2023.
2022
Greenberg ZJ, Monlish D, Paracatu LChiquetto, Dong Q, Rettig MP, Roundy NDee, Gaballa R, Li W, Yang W, Luke CJ, et al. The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex- mediated quiescence. Blood. 2022.
2021
Dou X, Zheng F, Zhang L, Jin J, Zhang Y, Liu B, Meng L, Zhu X, Lu Z, Jia Y, et al. Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study. Ann Hematol. 2021.
Adjei MOwusu, Xiang Y, He Y, Zhou X, Mao M, Liu J, Hu H, Luo J, Zhang H, Feng L, et al. Adventitious root primordia formation and development in the stem of var. slip. Plant Signal Behav. 2021:1949147.
Chen R, Okeyo-Owuor T, Patel RM, Casey EB, Cluster AS, Yang W, Magee JA. Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy. Cell Rep. 2021;34(7):108751.
Luo H, Bu D, Shao L, Li Y, Sun L, Wang C, Wang J, Yang W, Yang X, Dong J, et al. Single-cell Long Non-coding RNA Landscape of T Cells in Human Cancer Immunity. Genomics Proteomics Bioinformatics. 2021.
2020
Cao X, Tian T, Steele JW, Cabrera RM, Aguiar-Pulido V, Wadhwa S, Bhavani N, Bi P, Gargurevich NH, Hoffman EN, et al. Loss of RAD9B impairs early neural development and contributes to the risk for human spina bifida. Hum Mutat. 2020.
2019
Yang W, Zhu P, Huang H, Zheng Y, Liu J, Feng L, Guo H, Tang S, Guo R. Functionalization of Novel Theranostic Hydrogels with Kartogenin Grafted USPIO Nanoparticles to Enhance Cartilage Regeneration. ACS Appl Mater Interfaces. 2019.
Zhou K, Yu P, Shi X, Ling T, Zeng W, Chen A, Yang W, Zhou Z. Hierarchically Porous Hydroxyapatite Hybrid Scaffold Incorporated with Reduced Graphene Oxide for Rapid Bone Ingrowth and Repair. ACS Nano. 2019.

Pages